FDA Adverse Event Injury Summary report: N

POWERPICC, 3CG

MDR report key: 21766713 · Received April 3, 2025

Report

Report Number
3006260740-2025-02021
Event Type
Injury
Date Received
April 3, 2025
Date of Event
February 19, 2025
Report Date
April 4, 2025
Manufacturer
C.R. BARD, INC. (BASD) -3006260740
Product Code
LJS
UDI-DI
00801741139659
PMA / PMN Number
K091324
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

H11: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD.

Additional Manufacturer Narrative · 0

H11: SECTION A THROUGH F - THE INFORMATION PROVIDED BY BD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD. THE DEVICE HAS NOT BEEN RECEIVED BY THE MANUFACTURER FOR EVALUATION. EACH EVENT REPORTED TO BD IS EVALUATED AND INVESTIGATED IN ACCORDANCE WITH OUR COMPLAINT INVESTIGATION PROCEDURES. THE INVESTIGATION PROCESS INCLUDES, BUT IS NOT LIMITED TO, EVALUATION OF THE EVENT DETAILS PROVIDED BY THE COMPLAINT FACILITY, A REVIEW OF COMPLAINT HISTORY, MANUFACTURING RECORDS AND RISK DOCUMENT WHERE APPLICABLE, AND AN EVALUATION OF THE SUBJECT DEVICE WHEN AVAILABLE TO IDENTIFY POTENTIAL CONTRIBUTING FACTORS.

Description of Event or Problem · 0

ADDITIONAL INFORMATION RECEIVED 3/31: A NEW CATHETER WAS NOT PLACED. COMPLAINANT STATES THE EVENT CAUSED A CLINICALLY SIGNIFICANT DELAY IN TREATMENT BECAUSE IT OCCURRED DURING CHEMOTHERAPY INFUSION.

Description of Event or Problem · 0

IT WAS REPORTED LEAKING NOTED FROM PICC SITE WHEN CHEMOTHERAPY BEING ADMINISTERED. INFUSION STOPPED AND LEAKING STILL VISIBLE. PICC REMOVED AND INTERNAL FRACTURE NOTED. PATIENT REVIEWED BY DOCTOR AND TREATED FOR AN EXTRAVASATION AS PER POLICY. FOLLOW UP ARRANGED FOR PATIENT THE NEXT WORKING DAY. NO OTHER INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1847250 POWERPICC, 3CG PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) LJS C.R. BARD, INC. (BASD) -3006260740 N/A REJS3894 00801741139659

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other| R